[Federal Register Volume 72, Number 44 (Wednesday, March 7, 2007)]
[Notices]
[Pages 10112-10113]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-3935]


-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

Agricultural Research Service


Notice of Intent To Grant Exclusive License

AGENCY: Agricultural Research Service, USDA.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. Department of 
Agriculture, Agricultural Research Service, intends to grant to 
Hepalife Technologies, Inc. of Boston, Massachusetts, an exclusive 
license to U.S. Patent No. 5,532,156, ``Hepatocyte Cell Line Derived 
from the Epiblast of Pig Blastocysts'', issued on July 2, 8, 1996 and 
to U.S. Patent No. 5,866,420, ``Artificial Liver Device'', issued on 
February 1, 1999.

DATES: Comments must be received within thirty (30) calendar days of 
the date of publication of this Notice in the Federal Register.

ADDRESSES: Send comments to: USDA, ARS, Office of Technology Transfer, 
5601 Sunnyside Avenue, Room 4-1174, Beltsville, Maryland 20705-5131.

FOR FURTHER INFORMATION CONTACT: June Blalock of the Office of 
Technology Transfer at the Beltsville address given above; telephone: 
301-504-5989.

SUPPLEMENTARY INFORMATION: The Federal Government's intellectual 
property rights to this invention are assigned to the United States of 
America, as represented by the

[[Page 10113]]

Secretary of Agriculture. It is in the public interest to so license 
this invention as Hepalife Technologies, Inc. of Boston, Massachusetts 
has submitted a complete and sufficient application for a license. The 
prospective exclusive license will be royalty-bearing and will comply 
with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The 
prospective exclusive license may be granted unless, within thirty (30) 
days from the date of this published Notice, the Agricultural Research 
Service receives written evidence and argument which establishes that 
the grant of the license would not be consistent with the requirements 
of 35 U.S.C. 209 and 37 CFR 404.7.

Richard J. Brenner,
Assistant Administrator.
 [FR Doc. E7-3935 Filed 3-6-07; 8:45 am]
BILLING CODE 3410-03-P